STRS Ohio’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.13M | Buy |
24,200
+4,400
| +22% | +$211K | ﹤0.01% | 683 |
|
|
2026
Q1 | $1.02M | Buy |
19,800
+9,300
| +89% | +$474K | ﹤0.01% | 706 |
|
|
2025
Q4 | $522K | Hold |
10,500
| – | – | ﹤0.01% | 1062 |
|
|
2025
Q3 | $502K | Hold |
10,500
| – | – | ﹤0.01% | 1092 |
|
|
2025
Q2 | $331K | Sell |
10,500
-500
| -5% | -$16K | ﹤0.01% | 1469 |
|
|
2025
Q1 | $360K | Sell |
11,000
-1,000
| -8% | -$35.4K | ﹤0.01% | 1333 |
|
|
2024
Q4 | $434K | Sell |
12,000
-7,700
| -39% | -$271K | ﹤0.01% | 1257 |
|
|
2024
Q3 | $614K | Buy |
19,700
+6,000
| +44% | +$187K | ﹤0.01% | 1124 |
|
|
2024
Q2 | $366K | Buy |
+13,700
| New | +$397K | ﹤0.01% | 1374 |
|
|
2023
Q3 | – | Sell |
-24,900
| Closed | -$748K | – | 2043 |
|
|
2023
Q2 | $748K | Buy |
24,900
+1,500
| +6% | +$52.5K | ﹤0.01% | 1056 |
|
|
2023
Q1 | $847K | Buy |
23,400
+22,600
| +2,825% | +$869K | ﹤0.01% | 1011 |
|
|
2022
Q4 | $28K | Hold |
800
| – | – | ﹤0.01% | 1860 |
|
|
2022
Q3 | $27K | Buy |
+800
| New | +$26K | ﹤0.01% | 1906 |
|
|
2019
Q4 | – | Sell |
-90,000
| Closed | -$2.47M | – | 2138 |
|
|
2019
Q3 | $2.47M | Hold |
90,000
| – | – | 0.01% | 610 |
|
|
2019
Q2 | $2.98M | Hold |
90,000
| – | – | 0.01% | 570 |
|
|
2019
Q1 | $3.15M | Buy |
90,000
+13,000
| +17% | +$484K | 0.01% | 560 |
|
|
2018
Q4 | $2.56M | Sell |
77,000
-2,800
| -4% | -$120K | 0.01% | 582 |
|
|
2018
Q3 | $4.02M | Sell |
79,800
-1,500
| -2% | -$74.1K | 0.02% | 507 |
|
|
2018
Q2 | $4.87M | Sell |
81,300
-41,200
| -34% | -$2.13M | 0.02% | 485 |
|
|
2018
Q1 | $5.61M | Sell |
122,500
-6,300
| -5% | -$263K | 0.02% | 443 |
|
|
2017
Q4 | $5.13M | Buy |
128,800
+10,000
| +8% | +$395K | 0.02% | 474 |
|
|
2017
Q3 | $4.75M | Sell |
118,800
-3,000
| -2% | -$130K | 0.02% | 488 |
|
|
2017
Q2 | $5.25M | Sell |
121,800
-44,900
| -27% | -$1.6M | 0.02% | 460 |
|
|
2017
Q1 | $5.22M | Sell |
166,700
-42,870
| -20% | -$1.15M | 0.02% | 497 |
|
|
2016
Q4 | $5.29M | Sell |
209,570
-10,000
| -5% | -$223K | 0.02% | 493 |
|
|
2016
Q3 | $5.43M | Sell |
219,570
-30,000
| -12% | -$679K | 0.02% | 482 |
|
|
2016
Q2 | $5.08M | Sell |
249,570
-44,070
| -15% | -$782K | 0.02% | 477 |
|
|
2016
Q1 | $4.48M | Buy |
293,640
+10,000
| +4% | +$130K | 0.02% | 498 |
|
|
2015
Q4 | $3.81M | Buy |
283,640
+104,240
| +58% | +$1.61M | 0.02% | 539 |
|
|
2015
Q3 | $2.52M | Buy |
179,400
+160,500
| +849% | +$2.98M | 0.01% | 599 |
|
|
2015
Q2 | $320K | Buy |
+18,900
| New | +$269K | ﹤0.01% | 1465 |
|
Other funds holding SUPN
AC
NAMI
SIMG
STRS Ohio's SUPN Position: Q2 2026 in Review
STRS Ohio increased its Supernus Pharmaceuticals (SUPN) stake by 22% in Q2 2026, buying an estimated $211K and bringing the position to 24,200 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #683.
STRS Ohio first reported a position in SUPN in Q2 2015 and has held it in 31 quarters since. The position peaked at $5.61M in Q1 2018. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.
- STRS Ohio held 24,200 shares of Supernus Pharmaceuticals worth $1.13M as of Q2 2026.
- STRS Ohio bought 4,400 Supernus Pharmaceuticals shares in Q2 2026, an estimated $211K.
- Supernus Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #683 holding.
- STRS Ohio first reported a position in Supernus Pharmaceuticals in Q2 2015 and has held it in 31 quarters since.
- STRS Ohio's Supernus Pharmaceuticals position peaked at $5.61M in Q1 2018.
- 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.
Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.